ArticleFuture oncology (London, England)2021

Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer.

Benjamin J Solomon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.